StockWatch
·

BMW Industries Ltd Q2 FY27 Results

BMWQ2 FY27 Results
Filing
Result:Steady· Market: Up#Margin squeeze#One-off gain

Outlook: Neutral · Guidance: Maintained

MetricValue (₹ Cr)Q1 FY27Q2 FY26
Revenue181.509.3%25.3%
Total Income195.4210.6%33.0%
Expenditure166.629.8%31.9%
PBT28.8015.2%39.3%
Net Profit21.5713.3%43.5%
OPM19.18%1.12pp6.30pp
NPM11.04%0.26pp0.81pp
EPS0.9612.9%43.3%
View full financials

Revenue grew a healthy 25.3% but OPM contracted sharply from 25.48% to 19.18%, and most of the PAT growth came from a jump in other income (₹2.07cr to ₹13.92cr) rather than core operating performance, making this an in-line result for the metals/mining sector despite the headline profit growth.

BMW INDUSTRIES · Q2 FY27 · THE VERDICT

Strong Q2 Legacy Masks the Bokaro Margin Squeeze Ahead

BMW's Q2 growth is vigorous (25% revenue, 43% PAT), but it masks a looming margin cliff. The entire quarter is legacy business; once Bokaro ramps, EBITDA margins compress from 19.2% to 12%—management withheld FY27 guidance to avoid detailing it.

12 Nov 2026 · 6 min read
Q2 Revenue

₹182 Cr

+25% YoY, 100% legacy

Q2 OPM

19.2%

vs. 12% FY28 target

Q2 PAT

₹22 Cr

+43.5% YoY

Bokaro CTO

Oct 5, 2026

post-quarter; Q3 revenue starts

Growth is robust, but unsustainable. Q2's 19.2% operating margin reflects 100% legacy business—job-work fees with no raw material cost embedded in COGS. Bokaro enters at 7–8% EBITDA margin, dragging the blended rate to 12% by FY28. That's a 70-basis-point headwind. Management deferred full-year guidance rather than call out the margin cliff explicitly.

Where the quarter came from

All ₹182 Cr revenue is from legacy conversion business (coil galvanizing, pipes, tubes, coating). Bokaro's colour-coating line received Consent to Operate on October 5—after the quarter closed September 30—so Q2 saw zero contribution. Galvalume and ZAM lines follow in Q4 FY27 and H1 FY28 respectively. The business model differs materially: legacy is processing fees on customer-supplied raw material; Bokaro will be product sales with internal raw procurement and 60–65 days of working capital tie-up.

EBITDA Margin %
09.0518.1127.1624.25Legacy Q27.5Bokaro target12Consolidated FY28
Legacy at peak margins; Bokaro at half the rate. Consolidated target requires 60%+ Bokaro utilization by FY28.
I will refrain from doing that… very transitional phase for business; shorter-term guidance could make me look like a fool.
Management claims vs. what holds up
Claim on the callDelivered numberVerdict
Operating income ₹182 Cr, 25.3% YoY growth₹181.5 Cr revenue, 25.3% YoYSupported
EBITDA ₹35 Cr at 19.2% marginOPM 19.2%, consistent with stated profileSupported
PAT 42.7% YoY growth to ₹22 Cr₹21.6 Cr PAT, 43.5% YoYSupported
Revenue CAGR 70–75% FY25–FY28 on trackH1 FY27 ~₹350 Cr; full-year ~₹700+ Cr feasibleMixed—run-rate on pace, but FY27 guidance deferred
Bokaro operational post-Oct 5 CTOCTO Oct 5; Q2 (ended Sep 30) zero contributionSupported

What changed on this call

Nothing numeric was cut. Revenue CAGR 70–75%, margin targets (12% EBITDA, 5–6% PAT by FY28), and peak debt (₹800–900 Cr) were all reiterated. But scope narrowed sharply: management explicitly withheld FY27 full-year guidance, citing 'transitional phase.' This is new and signals execution caution. H1 FY27 revenue of ~₹350 Cr annualizes to ₹700+ Cr, on track for 70–75% growth, yet management chose not to quantify FY27. Bokaro capex is tracking (₹516 Cr deployed by Sep 30, ₹60 Cr capitalized Oct 5; ~₹227 Cr pending through COD Sep 2027).

The bull-bear ledger
  • 25% revenue growth and 43% PAT beat on strong legacy execution

  • Bokaro capex milestone (CTO Oct 5) on schedule; 3-phase ramp crystalline

  • 70–75% revenue CAGR reiterated; H1 run-rate on pace

  • Q2 margins (19.2% OPM) at peak; Bokaro (7–8%) will compress consolidated to 12%

  • Peak debt ₹800–900 Cr + ₹350–400 Cr working capital tie-up will strain cash

  • Competitive entry (Shyam, Godawari) in coated segment; pricing headwind likely

  • FY27 guidance withheld; management signals caution despite strong H1

Risks, ranked by how much they should concern a holder

Margin compression: Bokaro (7–8% EBITDA) dilutes legacy (24–25%)

High

70 bps headwind on consolidated EBITDA; immediate and material upon ramp. Q3 FY27 onwards, reported margin will compress visibly unless legacy growth offsets.

Bokaro execution risk: Galvalume (Q4 FY27), ZAM (H1 FY28) schedule slips

High

Delays cascade margin benefits and debt repayment. 3-line full ramp expected Q3/Q4 FY28; miss pushes consolidated 12% target into FY29.

Debt & working capital strain: Peak ₹800–900 Cr debt, ₹350–400 Cr WC tie-up

Medium

Existing legacy business must fund both Bokaro WC and debt service. Margin miss or revenue miss delays deleveraging. Leverage will peak near 4x before declining.

Competitive intensity: Shyam Metalics, Godawari entering coated segment; pricing pressure

Medium

Coated market 5–7M tons, growing 10–13%. BMW 2L tons is small. No pricing power vs. larger peers; competing on cost and execution speed. Margin assumptions aggressive.

Guidance visibility: FY27 withheld; management signals caution

Low

Investors lack near-term clarity despite strong H1. FY28 guidance reaffirmed, but credibility dented. Reaffirmation of 70–75% CAGR and 12% EBITDA target needed next quarter to restore confidence.

What to watch next
  • 1 · Q4 FY27: Galvalume line commissioned; Bokaro enters second product phase

    Colour-coated ramp established, but true multi-line production test begins. Watch for any delays or capacity utilization shortfalls. FY27 full-year revenue guidance expected (currently withheld); this will clarify management confidence.

  • 2 · H1 FY28: ZAM line online; 3-line capacity operational; consolidated ramp accelerates

    Full 5.5 lakh ton production stack active. Working capital draw will peak. Debt trajectory becomes clearer. Reported EBITDA margin should be 13–15% blended if Bokaro hits 40–50% utilization. This is the credibility test for FY28 margin guidance.

  • 3 · Q3/Q4 FY28: Full ramp and margin stabilization; consolidated EBITDA approaches 12%

    If Bokaro hits 60%+ utilization and legacy margins hold at 24%+, consolidated EBITDA should land near 12% (reiterated target). Validate or break the thesis. This is the number that determines fair value.

Steady execution, not a step-change. BMW's legacy business remains efficient and cash-generative; Bokaro is a real capex play with commodity-like margins, not an easy margin-boost. Q2's 19.2% OPM is a high-water mark for the next 18 months. The stock is priced for the guidance (70–75% CAGR, 12% EBITDA by FY28), not for the upside.

Risk/reward is balanced. Execution on Bokaro margins and working capital will determine fair value. Hold pending clarity on FY27 guidance (deferred) and Q3/Q4 FY28 consolidated margin delivery. The number to track from here: consolidated EBITDA margin in Q3/Q4 FY28, when the 3-line ramp settles. If it lands near 12%, thesis holds. If it overshoots or undershoots, the margin compression risk becomes clearer, and valuation should be reassessed.

Informational and educational content only. Not investment advice.